Only pay if approved·Free shipping·Cancel anytime·Provider supervised·HIPAA secure

Provider-prescribed treatments. Subject to medical evaluation. Medications are dispensed by licensed U.S. pharmacies.

Back to Blog
Comparisons
🔗 Linkable Asset 6/9/2026 7 min readBy EdenRx Medical Team

Semaglutide vs Tirzepatide: Which GLP-1 Is Right for You?

Semaglutide vs Tirzepatide: Which GLP-1 Is Right for You?

Ready to find out if you may qualify?

No payment required to start · Takes less than 60 seconds · Only pay if approved

Check Your Eligibility Free
No Payment Required Response Within 24h Built from Eden Med Spa

Key Takeaways

  • 1Semaglutide is a single GLP-1 receptor agonist; tirzepatide targets both GLP-1 and GIP receptors, potentially offering greater average weight loss outcomes.
  • 2Neither medication is universally superior — a licensed provider review is required to determine which option, if any, is appropriate for each individual patient.
  • 3EdenRx offers provider-reviewed GLP-1 telehealth weight loss programs for eligible patients in Florida and New York, with a free assessment and no upfront payment required.

Both semaglutide and tirzepatide are GLP-1 receptor agonists that may help eligible patients achieve meaningful weight loss when combined with lifestyle changes. The right choice between them depends on your health history, goals, and a provider review — no single medication is universally best.

Ready to find out if you qualify? Start Free Assessment — No payment required

What Is Semaglutide and How Does It Work?

Semaglutide is a GLP-1 receptor agonist originally developed to manage type 2 diabetes and later studied extensively for chronic weight management. It works by mimicking the glucagon-like peptide-1 hormone, which helps regulate appetite signals in the brain, slows gastric emptying, and may reduce overall caloric intake in eligible individuals. Brand names you may recognize include Ozempic® (diabetes indication) and Wegovy® (weight management indication).

In clinical trials, once-weekly semaglutide injections were associated with an average body weight reduction of approximately 15% over 68 weeks when paired with diet and exercise. Results vary significantly from person to person, and not everyone experiences the same outcomes. If you are exploring GLP-1 weight loss programs, semaglutide is often considered a well-established starting point that providers may recommend for appropriate candidates.

What Is Tirzepatide and How Is It Different?

Tirzepatide is a newer dual-agonist medication that targets both the GLP-1 receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor simultaneously. This dual mechanism may offer an additional layer of appetite and metabolic regulation compared to single-agonist options. Tirzepatide is marketed under the brand name Mounjaro® for type 2 diabetes and Zepbound® for chronic weight management.

Because tirzepatide activates two hormonal pathways, some clinical studies have shown potentially greater average weight loss outcomes compared to semaglutide — with some trial participants losing up to 20–22% of body weight over approximately 72 weeks. However, individual results vary, and tirzepatide is not automatically the "better" choice for every patient. A provider review through our online weight loss program is the only way to determine which medication, if any, may be appropriate for your specific situation.

Semaglutide vs Tirzepatide: Side-by-Side Comparison

Both medications share a similar side effect profile, most commonly gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation — particularly during the dose escalation phase. These effects are generally mild to moderate and tend to diminish over time for many patients. Neither medication is appropriate for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

The table below outlines key differences to help frame your conversation with a provider:

| Feature | Semaglutide | Tirzepatide | |---|---|---|
| Mechanism | GLP-1 agonist | GLP-1 + GIP dual agonist | | Administration | Once-weekly injection | Once-weekly injection | | Avg. Weight Loss (trials) | ~15% body weight | ~20–22% body weight | | FDA Approval (weight) | Yes (Wegovy®) | Yes (Zepbound®) | | Common Side Effects | Nausea, GI upset | Nausea, GI upset | | Availability | Widely available | Growing availability | | Compounded Options | Potentially available | Potentially available |

Results vary. Clinical averages do not predict individual outcomes. Eligibility and medication selection determined by a licensed provider.

How GLP-1s Compare to Diet and Exercise Alone

Many patients wonder whether GLP-1 medications offer an advantage over traditional diet and lifestyle changes. The short answer is: for eligible individuals, these medications may significantly amplify the results that diet and exercise alone can achieve. As explored in our GLP-1 vs diet comparison guide, lifestyle modification remains a cornerstone of any weight loss plan — but GLP-1 medications may help address the biological hunger and satiety signals that make sustained weight loss so difficult.

This is not about replacing healthy habits — it is about giving your biology a potential assist. Patients who engage in structured nutrition and movement plans alongside GLP-1 therapy may potentially see more consistent and sustainable outcomes. EdenRx's programs are designed to support both the medical and lifestyle dimensions of your weight loss journey, and our programs page outlines exactly what that looks like.

Why Provider Review Matters

Choosing between semaglutide and tirzepatide is not a decision that should be made based on online research alone — and at EdenRx, it never is. Every patient who moves forward through our platform receives a thorough review by a licensed medical provider who evaluates your health history, current medications, BMI, comorbidities, and personal goals before recommending any treatment. No medication is prescribed without that individualized review.

This matters because certain contraindications, drug interactions, or health conditions may make one medication more appropriate — or neither medication appropriate — for a given patient. Our providers in Florida and New York are equipped to guide you through this decision with clinical precision and genuine care. You can explore transparent pricing and the full scope of our weight loss programs before committing to anything. If eligible, your provider will work with you to identify the most suitable path forward.

Not sure where to start? Take the Free Assessment and let a licensed provider review your eligibility — available in Florida and New York.

What to Expect When You Start a GLP-1 Program

If you are deemed eligible after your provider review, most GLP-1 programs begin at a low starting dose and titrate upward over several weeks or months to minimize side effects and allow your body to adjust. Consistent weekly administration and follow-up check-ins are important parts of a medically supervised program. EdenRx's GLP-1 weight loss program includes ongoing provider access to support you through each phase.

Patients should set realistic expectations: weight loss with GLP-1 medications is typically gradual, and the most meaningful results are often seen over a period of months rather than weeks. These are not quick fixes — they are potentially powerful tools within a comprehensive, provider-directed plan. Results vary based on adherence, individual biology, dosage, and lifestyle factors.

Built on Real Care

Built from Eden Med Spa — real patients, real treatments.

EdenRx was built on the foundation of Eden Med Spa's real-world clinical experience treating patients with medically supervised weight loss programs. That hands-on background means our telehealth platform is grounded in practical, patient-centered care — not just algorithms. We bring that same commitment to every assessment, every provider interaction, and every treatment plan delivered through tryedenrx.org.

Frequently Asked Questions

Is semaglutide or tirzepatide more effective for weight loss? Clinical trial data suggests that tirzepatide may be associated with greater average weight loss outcomes compared to semaglutide, but individual results vary significantly. The most effective medication for you depends on your personal health profile and will be determined by a licensed provider, not averages.

Can I choose which GLP-1 medication I want? You can express a preference, but the final recommendation is made by your EdenRx provider after reviewing your health history, medical eligibility, and goals. Patient safety and clinical appropriateness always guide the selection.

Are compounded versions of these medications available? Compounded semaglutide and tirzepatide may potentially be available through licensed compounding pharmacies for eligible patients, subject to provider approval and current regulatory guidelines. Availability may vary.

What are the most common side effects of GLP-1 medications? The most commonly reported side effects include nausea, vomiting, diarrhea, and constipation — particularly during the dose escalation period. These symptoms are often temporary and may be managed with dosing adjustments under provider guidance.

Is EdenRx available outside of Florida and New York? Currently, EdenRx's provider-reviewed telehealth weight loss services are available to patients in Florida and New York only. We are not able to serve patients outside these states at this time.

How do I get started with EdenRx? Begin by completing the free online assessment at tryedenrx.org. There is no payment required to find out if you may qualify. If eligible, a licensed provider will review your information and outline next steps, including program and pricing details.

The Bottom Line

When it comes to semaglutide vs tirzepatide, there is no one-size-fits-all answer. Both are clinically studied, provider-prescribed GLP-1 medications that may help eligible patients achieve meaningful weight loss as part of a comprehensive program. Tirzepatide's dual mechanism may offer greater average results for some patients, while semaglutide remains a well-studied and widely available option with a strong clinical track record. The decision belongs to you and your provider — together.

EdenRx makes that conversation accessible, transparent, and medically sound. If you are in Florida or New York and ready to explore what may be possible, start your free assessment today. No payment required, no obligation — just a straightforward first step toward a provider-reviewed plan that is built around you.

Start Your Free Assessment → | View Programs & Pricing | Learn About GLP-1 Weight Loss

See if you qualify in 60 seconds

Provider-reviewed · Only pay if approved · Cancel anytime

Start Free Medical Assessment
No Payment Required Response Within 24h Built from Eden Med Spa
semaglutide tirzepatide GLP-1 weight loss telehealth EdenRx compounded semaglutide GLP-1 comparison Florida weight loss New York weight loss

Share This Article

Share Text

Semaglutide or tirzepatide — which GLP-1 is right for you? EdenRx breaks down the differences and how a provider helps you choose. Free assessment available in FL & NY. 🔗 tryedenrx.org

No payment required to start — get up to $50 off your first month.

A licensed provider reviews every case. Only pay if approved. Cancel anytime.

Start Free Medical Assessment
No Payment Required Response Within 24h Built from Eden Med Spa
Live Activity
149 people online now
1,076 visits today
10 orders shipped today
HIPAA Secure